Intravenous immunoglobulin therapy: how does IgG modulate the immune system?

I Schwab, F Nimmerjahn - Nature Reviews Immunology, 2013 - nature.com
Intravenous immunoglobulin (IVIG) preparations comprise pooled IgG antibodies from the
serum of thousands of donors and were initially used as an IgG replacement therapy in …

Intravenous immune globulin in autoimmune and inflammatory diseases

EW Gelfand - New England Journal of Medicine, 2012 - Mass Medical Soc
Intravenous Immune Globulin in Autoimmune and Inflammatory Diseases | New England Journal
of Medicine Skip to main content The New England Journal of Medicine homepage Advanced …

Enhancement of the blood-circulation time and performance of nanomedicines via the forced clearance of erythrocytes

MP Nikitin, IV Zelepukin, VO Shipunova… - Nature biomedical …, 2020 - nature.com
The rapid elimination of nanoparticles from the bloodstream by the mononuclear phagocyte
system limits the activity of many nanoparticle formulations. Here, we show that inducing a …

A case for regulatory B cells

A Mizoguchi, AK Bhan - The Journal of Immunology, 2006 - journals.aai.org
B cells are typically characterized by their ability to produce Abs, including autoantibodies.
However, B cells possess additional immune functions, including the production of cytokines …

Anti-inflammatory actions of intravenous immunoglobulin

F Nimmerjahn, JV Ravetch - Annu. Rev. Immunol., 2008 - annualreviews.org
The remarkable success story of the therapeutic application of pooled immunoglobulin G
(IgG) preparations from thousands of donors, the so-called intravenous IgG (IVIG) therapy, to …

Apoptosis in the anucleate platelet

V Leytin - Blood reviews, 2012 - Elsevier
For many years, programmed cell death, known as apoptosis, was attributed exclusively to
nucleated cells. Currently, however, apoptosis is also well-documented in anucleate …

[HTML][HTML] Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases

N Li, M Zhao, J Hilario-Vargas… - The Journal of …, 2005 - Am Soc Clin Investig
Numerous mechanisms of action have been proposed for intravenous Ig (IVIG). In this study,
we used IgG passive transfer murine models of bullous pemphigoid (BP), pemphigus …

Intravenous immunoglobulin ameliorates ITP via activating Fcγ receptors on dendritic cells

V Siragam, AR Crow, D Brinc, S Song, J Freedman… - Nature medicine, 2006 - nature.com
Despite a more than 20-year experience of therapeutic benefit, the relevant molecular and
cellular targets of intravenous immunoglobulin (IVIg) in autoimmune disease remain …

The management of peripheral blood cytopenias in systemic lupus erythematosus

AL Hepburn, S Narat, JC Mason - Rheumatology, 2010 - academic.oup.com
Haematological complications are frequently seen in SLE. Anaemia, leucopenias and
thrombocytopenia may result from bone marrow failure or excessive peripheral cell …

Modulation of the cellular immune system by intravenous immunoglobulin

T Tha-In, J Bayry, HJ Metselaar, SV Kaveri… - Trends in …, 2008 - cell.com
Intravenous immunoglobulin (IVIg) is therapeutically used in a variety of immune-mediated
diseases. The beneficial effects of IVIg in auto-antibody-mediated diseases can be …